Colostrum Proteins in Protection against Therapy-Induced Injuries in Cancer Chemo- and Radiotherapy: A Comprehensive Review
Open Access
- 3 January 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 114
Abstract
In this article, we review the benefits of application of colostrum and colostrum-derived proteins in animal models and clinical trials that include chemotherapy with antimetabolic drugs, radiotherapy and surgical interventions. A majority of the reported investigations was performed with bovine colostrum (BC) and native bovine or recombinant human lactoferrin (LF), applied alone, in nutraceutics or in combination with probiotics. Apart from reducing side effects of the applied therapeutics, radiation and surgical procedures, BC and LF augmented their efficacy and improved the wellness of patients. In conclusion, colostrum and colostrum proteins, preferably administered with probiotic bacteria, are highly recommended for inclusion to therapeutic protocols in cancer chemo- and radiotherapy as well as during the surgical treatment of cancer patients.Keywords
This publication has 161 references indexed in Scilit:
- A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis*Critical Care Medicine, 2013
- “Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in miceBMC Cancer, 2012
- Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma RatsMolecular Pharmaceutics, 2010
- Efficacy and Safety of Oral Lactoferrin Supplementation in Combination with rHuEPO-β for the Treatment of Anemia in Advanced Cancer Patients Undergoing Chemotherapy: Open-Label, Randomized Controlled StudyThe Oncologist, 2010
- Human lactoferrin stimulates skin keratinocyte function and wound re-epithelializationBritish Journal of Dermatology, 2010
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)BMC Medicine, 2009
- Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartmentImmunobiology, 2003
- Antibacterial prophylaxis with lactoferrin in neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948